Clinically significant Prostate Cancer diagnosed using a urinary molecular biomarker-based risk score: two case reports
Sign Up to like & getrecommendations! Published in 2019 at "BMC Urology"
DOI: 10.1186/s12894-019-0561-6
Abstract: BackgroundIdentifying men for a repeat prostate biopsy is a conundrum to urologists. Risk calculators (RCs) such as the European Randomized Study of Screening for Prostate Cancer (ERSPC) RCs have been developed to predict the outcome… read more here.
Keywords: prostate; molecular biomarker; risk; biomarker ... See more keywords